News
1d
Zacks Investment Research on MSNIs Chewy's Multi-Segment Approach the Formula for Scalable Growth?Chewy Inc. CHWY delivered a strong and well-rounded performance across all major segments in the first quarter of fiscal 2025. Net sales rose 8.3% year over year to $3.12 billion, exceeding the high ...
5d
Zacks Investment Research on MSNChewy (CHWY) is Attracting Investor Attention: Here is What You Should KnowChewy (CHWY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Incyte Corp's new chief executive, Bill Meury, outlined a growth strategy on Tuesday focused on accelerating drug development and prudent capital allocation, as the company faces the looming patent ...
New Wegovy prescriptions have increased by about 33% since May 22, when a U.S. Food and Drug Administration ban on so-called ...
Check out our HEALTH stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.
Check out our AHR stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results